Assignee
BIOTEST AG
DE29 patents
Top patents by PatentIndex Score
US7452981B2Nov 18, 2008
Humanized anti-CD4 antibody with immunosuppressive properties
BIOTEST AG90 citations97
US9758581B2Sep 12, 2017
Humanized anti-CD4 antibody with immunosuppressive properties
BIOTEST AG18 citations91
US5523214AJun 4, 1996
Method of visually demonstrating the presence of microorganisms, identifying them, and testing them for sensitivity to antibiotics with redox indicators
BIOTEST AG26 citations90
US7659247B2Feb 9, 2010
Production of a von Willebrand factor preparation having a high specific activity
BIOTEST AG28 citations89
US6120989ASep 19, 2000
Isolated human cytomegalovirus polypeptides and uses thereof
BIOTEST AG37 citations88
US10117932B2Nov 6, 2018
Uses of immunoconjugates targeting CD138
BIOTEST AG7 citations80
US6617126B1Sep 9, 2003
Method for improving the growth and colorimetric detection of bacteria, yeasts, fungi or cocci
BIOTEST AG9 citations73
US6168930B1Jan 2, 2001
Change in system
BIOTEST AG11 citations73
US5213963AMay 25, 1993
Procedure for finding and identifying red cell antibodies by means of the solid phase method
BIOTEST AG14 citations69
US4925786AMay 15, 1990
Method of determining blood groups by the solid-phase procedure with blood-group specific antibodies of the immunoglobulin M. type and support and kit for carrying out the method
BIOTEST AG8 citations69
US5358845AOct 25, 1994
Method of detecting proteins in body fluids and means of carrying out the method
BIOTEST AG7 citations65
US6908745B2Jun 21, 2005
Gamma sterilizable culture medium for the identification of yeasts and fungi
BIOTEST AG2 citations62
US11780909B2Oct 10, 2023
Methods of treating viral infections by administering an antibody preparation comprising IGG, IGA and IGM
BIOTEST AG0 citations59
US10954290B2Mar 23, 2021
IgG, IgA and IgM antibody preparations, method of making and method of use in treatment
BIOTEST AG0 citations59
US7939643B2May 10, 2011
Production of a von Willebrand factor preparation using hydroxylapatite
BIOTEST AG3 citations59
US6177080B1Jan 23, 2001
Polypeptides encoded by Kaposi sarcoma-associated herpes virus the use thereof in diagnosis and therapy
BIOTEST AG3 citations59
US12186391B2Jan 7, 2025
Treatment of severe community acquired pneumonia
BIOTEST AG0 citations57
US11517621B2Dec 6, 2022
Treatment of severe community acquired pneumonia
BIOTEST AG0 citations57
US10918715B2Feb 16, 2021
Treatment of severe community acquired pneumonia
BIOTEST AG0 citations57
US9243056B2Jan 26, 2016
Process for preparing an immunoglobulin composition
BIOTEST AG1 citations57
US12487244B2Dec 2, 2025
Method and kit for testing potency of immunoglobulin compositions
BIOTEST AG0 citations49
US10059759B2Aug 28, 2018
Antibody preparations
BIOTEST AG0 citations49
US9540436B2Jan 10, 2017
Use of antibodies for detection of IL-10
BIOTEST AG0 citations49
US9518110B2Dec 13, 2016
Antibody preparations
BIOTEST AG0 citations49
US8900806B2Dec 2, 2014
Antibody preparations
BIOTEST AG0 citations49
US9605066B2Mar 28, 2017
Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)
BIOTEST AG0 citations48
US7863420B2Jan 4, 2011
Process for removing fibronectin from plasma fractions
BIOTEST AG0 citations48
US11325964B2May 10, 2022
Process for preparing immunoglobulin compositions
BIOTEST AG0 citations42
US12264191B2Apr 1, 2025
De-immunized factor VIII molecule and pharmaceutical compositions comprising the same
BIOTEST AG0 citations37